Szendröi M, Lapis K, Zalatnai A, Robert L, Labat-Robert J
1st Institute of Pathology and Experimental Cancer Research, Semmelweis University Medical School, Budapest, Hungary.
J Exp Pathol. 1984 Summer;1(3):189-99.
The distribution of a high-molecular-weight glycoprotein, fibronectin (FN), was studied by immunohistochemical methods in putative preneoplastic lesions, as well as in fully developed hepatocellular carcinomas, formed in rats during chemical hepatocarcinogenesis, and in 10 human hepatomas. All but two preneoplastic lesions contained FN in their intercellular matrix. FN was present around groups of transformed liver cells, as well as on the surfaces and in the cytoplasms of certain cells. A similar, typically altered, distribution pattern was seen in the majority of the carcinomas studied. Six out of seven human hepatocellular carcinomas were found to contain FN. In three cases of cholangiocarcinoma, FN was, however, confined to the reactive stroma only. The presence of FN in hepatomas, which is in contrast to carcinomas of other organs, may serve as a marker for the demonstration of preneoplastic lesions of experimental carcinogenesis and for diagnostic differentiation of human hepatomas.
采用免疫组织化学方法,研究了高分子量糖蛋白纤连蛋白(FN)在化学性肝癌发生过程中大鼠形成的假定癌前病变以及完全发展的肝细胞癌,以及10例人类肝癌中的分布情况。除两个癌前病变外,所有病变的细胞间基质中均含有FN。FN存在于转化肝细胞群周围,以及某些细胞的表面和细胞质中。在所研究的大多数癌中也观察到了类似的、典型改变的分布模式。在7例人类肝细胞癌中,有6例发现含有FN。然而,在3例胆管癌中,FN仅局限于反应性基质。与其他器官的癌不同,肝癌中FN的存在可能作为实验性致癌癌前病变的示踪标记以及人类肝癌诊断鉴别的标记。